Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles
Mohammed Salah Ayoup, Islam Shawki, Hamida Abdel-Hamid, Doaa A. Ghareeb, Aliaa Masoud, Marwa F. Harras, Mohamed El-Atawy, Nuha Salamah Alharbi, Magda M. F. Ismail
TL;DR
This paper corrects a previously published study on new compounds targeting cancer-related signaling pathways in lung and colon cancers.
Contribution
The paper provides corrections to a prior study on the synthesis and evaluation of antitumor compounds.
Findings
The paper identifies errors in the original study's data or methodology.
It offers revised information to improve the accuracy of the findings.
Abstract
Correction for ‘Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles’ by Mohammed Salah Ayoup et al., RSC Adv., 2024, 14, 16713–16726, https://doi.org/10.1039/D4RA02222J.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSynthesis and biological activity